Tennis elbow treatment: Steroid injection and/or kinesiotaping

Comparison of steroid injection and kinesiotaping for the treatment of lateral epicondylitis? A single-blinded randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180108038268N2

Enrollment

Registered

2018-03-10

Start date

2018-02-15

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicondylitis. Lateral epicondylitis

Interventions

Intervention 1: Intervention group1: steroid injection group. Intervention 2: Intervention group2: kinesiotape group. Intervention 3: Intervention group 3: both steroid injection and kinesiotape group

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Clinically diagnosed with lateral epicondylitis (pain in the lateral aspect of the elbow joint, tenderness on the lateral epicondyle, pain during wrist extension) Unilateral complaint Having complaints for at least two weeks

Exclusion criteria

Exclusion criteria: History of inflammatory arthritis Having previously received lateral epicondylitis treatment History of elbow surgery Oral or systemic use of steroids Cervical radiculopathy History of tendon rupture History of fracture of humerus, radius or ulna History of malignancy History of coagulopathy Cognitive function disorder Contraindications of local injections (infections, bleeding disorders, allergy for steroids and/or locak anesthetics)

Design outcomes

Primary

Measure	Time frame
Pain will be assessed at rest and during activity separately. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Pain will be assessed at rest and during activity separately with Visual Analogue Scale (VAS) (0-10).;Hand grip strength. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Maximum painless hand grip strength will be measured with hand dynamometer.;Pressure pain threshold on lateral epicondyle. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Pressure pain threshold on lateral epicondyle will be measured with an algometer.;Functional status. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Functional status will be assessed using the rapid form of “Disabilities of Arm Shoulder and Hand Questionnaire” (q-DASH).	—

Measure

Time frame

Pain will be assessed at rest and during activity separately. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Pain will be assessed at rest and during activity separately with Visual Analogue Scale (VAS) (0-10).;Hand grip strength. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Maximum painless hand grip strength will be measured with hand dynamometer.;Pressure pain threshold on lateral epicondyle. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Pressure pain threshold on lateral epicondyle will be measured with an algometer.;Functional status. Timepoint: Measurement will be repeated before treatment and after the third and twelfth weeks following treatment. Method of measurement: Functional status will be assessed using the rapid form of “Disabilities of Arm Shoulder and Hand Questionnaire” (q-DASH).

—

Countries

Turkey

Contacts

Public ContactFatmanur Aybala Koçak

Ahi Evran University Faculty of Medicine Department of Physical Medicine and Rehabilitation

faybalarem@gmail.com+90 386 213 45 15

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026